Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
Published March 23, 2022 · Recall initiated: March 2, 2022
Summary
FDA records drug Class II recall D-0654-2022, published March 23, 2022 and initiated March 2, 2022. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 401 bottles; Lot: Lot #: GS027852, Expiry: 06/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Golden State Medical Supply Inc.
- Distributor
- Distributed to 1 wholesaler/distributor
- Lot
- Lot #: GS027852, Expiry: 06/2022.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CASeptember 9, 2026
- FDACarbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottlesAugust 26, 2026
- FDAGSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured byJune 17, 2026
- FDAPrimidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by:May 27, 2026
- FDAhydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by:March 23, 2022
- FDA0.9% Sodium Chloride Injection USP, 250 mL Excel Container, Rx only, B. Braun Medical Inc., Bethlehem, PA, NDCMarch 23, 2022
Questions about this recall
Was Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18. recalled?
Yes. FDA published recall D-0654-2022 on March 23, 2022. Reported hazard: CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
What should I do if I have this product?
Voluntary: Firm initiated · Letter